HYBRID EVENT: You can participate in person at Rome, Itlay or Virtually from your home or work.

11th Edition of International Conference on

Neurology and Neurological Disorders

June 05-07, 2025 | Rome, Italy

Mild Cognitive Impairment

Mild Cognitive Impairment

Mild cognitive impairment, or MCI, is a condition wherein a person experiences minor changes in memory and cognitive function, but not to the degree of disability or impairment seen in dementia. It is not a disease or a symptom of dementia; rather, it is a pattern of cognitive changes that can be caused by disease, injury, or aging. While many patients do not progress to dementia, they may experience changes in mental abilities that can impact daily life. One of the most commonly reported symptoms of MCI is difficulty with short-term memory, such as remembering lists, Where a person put their items, Or new names or information. MCI can also affect a person’s problem-solving abilities or the ability to interpret and respond to new situations. Other common signs include difficulty with planning and organization, making decisions, and recalling information learned previously. MCI is diagnosed through a variety of tests, including memory and cognitive tests, physical exams, blood tests, psychological assessments, and imaging tests. Treatment depends on the cause of the MCI. If the cause is a reversible condition, such as depression, lifestyle changes and medications may be recommended. If a physical condition is identified, such as a thyroid disorder or vitamin deficiency, treatment may be necessary. In some cases, no cause can be identified and treatment focuses on managing the cognitive impairment. Management strategies may include lifestyle modifications such as continuing to exercise and engaging in regular cognitive activity. Memory aids and assistance with organization and decision making can also be helpful. Medications for cognitive problems in other conditions (such as Alzheimer’s disease) are not recommended as they have not been found to improve memory or reduce the risk of progressing to dementia. For those with mild cognitive impairment, living a healthy lifestyle, staying socially engaged, and continuing to employ problem-solving and cognitive strategies is essential for managing MCI.

Committee Members
Speaker at Neurology and Neurological Disorders 2025 - Ken Ware

Ken Ware

NeuroPhysics Therapy Institute, Australia
Speaker at Neurology and Neurological Disorders 2025 - Robert B Slocum

Robert B Slocum

University of Kentucky HealthCare, United States
Speaker at Neurology and Neurological Disorders 2025 - Luiz Moutinho

Luiz Moutinho

University of Suffolk, United Kingdom
Neurology 2025 Speakers
Speaker at Neurology and Neurological Disorders 2025 - David Lominadze

David Lominadze

University of South Florida, United States
Speaker at Neurology and Neurological Disorders 2025 - Dixie J Woolston

Dixie J Woolston

Mayo Clinic Arizona/Scottsdale, United States
Speaker at Neurology and Neurological Disorders 2025 - David Sperbeck

David Sperbeck

Private Practice, United States
Speaker at Neurology and Neurological Disorders 2025 - Sang Hie Lee

Sang Hie Lee

University of South Florida, United States
Tags

Submit your abstract Today

Watsapp